HUMA

Humacyte News

FREE HUMA REPORT

Company Name Stock Ticker Symbol Market Type
Humacyte Inc HUMA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.18 6.92% 2.78 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.61 2.61 2.81 2.78 2.60
more quote information »

Recent News

Date Time Source Heading
1/27/202311:59IHNWFeatured1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition
12/13/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
12/12/202216:15EDGARStatement of Changes in Beneficial Ownership (4)
12/12/202216:15EDGARStatement of Changes in Beneficial Ownership (4)
12/12/202216:14EDGARStatement of Changes in Beneficial Ownership (4)
12/12/202216:12EDGARStatement of Changes in Beneficial Ownership (4)
12/12/202216:05EDGARCurrent Report Filing (8-k)
11/10/202210:30TRMNAnalysts Offer Insights on Healthcare Companies: Arcturus..
11/10/202208:57EDGARQuarterly Report (10-q)
11/10/202207:05EDGARCurrent Report Filing (8-k)
9/20/202216:10EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202216:48EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202216:44EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202216:42EDGARInitial Statement of Beneficial Ownership (3)
9/19/202216:40EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
9/19/202216:37EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202216:35EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202216:33EDGARStatement of Changes in Beneficial Ownership (4)
9/15/202206:33EDGARNotice of Effectiveness (effect)
9/12/202206:31EDGARPost-effective Amendment to Registration Statement (pos Am)
9/12/202206:03EDGARNotice of Effectiveness (effect)
9/12/202206:02EDGARNotice of Effectiveness (effect)
9/09/202216:44EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
9/09/202216:42EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
9/01/202216:15EDGARSecurities Registration Statement (simplified Form) (s-3)
9/01/202216:09EDGARSecurities Registration Statement (simplified Form) (s-3)
8/12/202212:25TRMNHumacyte (HUMA) Gets a Buy from BTIG
8/12/202209:13EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/12/202208:50EDGARQuarterly Report (10-q)
8/12/202207:05EDGARCurrent Report Filing (8-k)
7/12/202205:36TRMNBTIG Thinks Humacyte’s Stock is Going to Recover
6/13/202216:23EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:23EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:23EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:22EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:22EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:22EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:21EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:17EDGARInitial Statement of Beneficial Ownership (3)
6/13/202216:06EDGARCurrent Report Filing (8-k)
5/25/202211:47EDGARStatement of Changes in Beneficial Ownership (4)
5/25/202210:23EDGARStatement of Changes in Beneficial Ownership (4)
5/25/202210:21EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202218:17EDGARStatement of Changes in Beneficial Ownership (4)
5/13/202210:25TRMNBTIG Thinks Humacyte’s Stock is Going to Recover
5/13/202208:47EDGARQuarterly Report (10-q)
5/13/202207:04EDGARCurrent Report Filing (8-k)
4/05/202216:41EDGARStatement of Changes in Beneficial Ownership (4)
4/05/202216:38EDGARInitial Statement of Beneficial Ownership (3)
4/04/202217:23EDGARProspectus Filed Pursuant to Rule 424(b)(7) (424b7)
4/01/202206:30EDGARNotice of Effectiveness (effect)